Flexible and steerable elongate instruments with shape control and support elements
    2.
    发明授权
    Flexible and steerable elongate instruments with shape control and support elements 有权
    灵活和可操纵的细长仪器,具有形状控制和支撑元件

    公开(公告)号:US09254123B2

    公开(公告)日:2016-02-09

    申请号:US12432683

    申请日:2009-04-29

    摘要: An instrument having a flexible and elongated body includes at least a lumen and a flex member disposed within the lumen. The flex member may be capable of providing steering control to a first portion of the elongate body while providing load bearing support to a second portion of the elongate body. A pull wire may be disposed within the flex member, and at least a distal portion of the pull wire may be coupled to the elongate body and a proximal portion of the pull wire may be operatively coupled to a control unit. The control unit may be coupled to a proximal portion of the elongate body. In addition, a control member may be operatively coupled to the control unit such that a distal portion of the control member may be positioned near a proximal portion of the flex member. The control member may be configured to support the flex member and control the movement or displacement of the flex member. Furthermore, the flex member may be configured to selectively decouple articulation or steering forces of a first portion of the elongate body away from a second portion of the elongate body; thereby, preventing compression of the second portion of the elongate body while maintaining elasticity or flexibility of the second portion of the elongate body.

    摘要翻译: 具有柔性和细长主体的器械包括至少一个内腔和设置在内腔内的柔性构件。 柔性构件可以能够向细长主体的第一部分提供转向控制,同时向细长主体的第二部分提供承载支撑。 拉线可以设置在柔性构件内,并且牵引线的至少远端部分可以联接到细长主体,并且拉线的近侧部分可以可操作地联接到控制单元。 控制单元可以联接到细长主体的近端部分。 此外,控制构件可以可操作地联接到控制单元,使得控制构件的远侧部分可以定位在柔性构件的近侧部分附近。 控制构件可以被配置为支撑柔性构件并且控制柔性构件的运动或位移。 此外,柔性构件可以被构造成选择性地将细长体的第一部分的铰接或转向力分离离开细长体的第二部分; 从而防止细长主体的第二部分的压缩,同时保持细长主体的第二部分的弹性或柔性。

    Apparatus and method of combining multiple laser beams using a negative focal length radial gradient index rod lens

    公开(公告)号:US10795172B1

    公开(公告)日:2020-10-06

    申请号:US16136763

    申请日:2018-09-20

    申请人: Casey Lewis

    发明人: Casey Lewis

    摘要: An apparatus and an improved method of combining multiple laser beams into a single output beam, using a Gradient-Index (GRIN) rod with a negative, radial gradient. Using a rod of sufficient diameter and length, the input angle of a laser could be increased to allow room for a second laser to be placed beside the first laser, such that the beam enters the rod at any point within a certain acceptance cone, and at an angle determined by its place within that cone, ranging from zero degrees to the maximum acceptance angle. This can be used to allow an almost unlimited number of lasers to be use to boost the energy, power, or altering the apparent color of lasers by combining multiple beams along a single axis.

    Methods and Systems for Medication Compliance Monitoring and Notification
    4.
    发明申请
    Methods and Systems for Medication Compliance Monitoring and Notification 审中-公开
    药物依从性监测和通报方法与系统

    公开(公告)号:US20170004283A1

    公开(公告)日:2017-01-05

    申请号:US15200111

    申请日:2016-07-01

    申请人: Casey Lewis

    发明人: Casey Lewis

    IPC分类号: G06F19/00

    CPC分类号: G06F19/3456 G16H10/60

    摘要: Systems and methods for facilitating adherence with a prescribed medication. A method for notifying a user about a prescribed medication and recording adherence with that prescribed medication includes the steps of: (i) installing a mobile application on a computing device; (ii) setting one or more medication reminders; (iii) receiving, by a user via the mobile application, a medication reminder; (iv) receiving a request for input regarding whether the medication was taken; (v) providing input regarding whether the medication was taken; and (vi) receiving a medication routine adherence report which includes information about the user's adherence with the medication routine.

    摘要翻译: 用于促进与规定药物依从性的系统和方法。 用于通知用户关于规定的药物并记录与该处方药物的依从性的方法包括以下步骤:(i)在计算设备上安装移动应用; (ii)设置一个或多个药物提醒; (iii)由用户通过移动应用接收药物提示; (iv)收到关于药物服用的投诉请求; (v)就药物是否服用提供意见; 和(vi)接收包括关于用户遵守用药程序的信息的药物常规依从性报告。